Tag Archives: Eli Lilly

Amyvid (Florbetapir 18F) Solution for Injection Recommended for Approval in Europe as a Diagnostic Tool for Imaging Beta-Amyloid Plaques – a Common Neuropathological Feature of Alzheimer’s Disease

– Milestone reflects Eli Lilly and Company’s commitment to bring new diagnostic tool to physicians evaluating patients’ cognitive decline

INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc.,

© Copyright 2016 South Africa News Gazette | All Rights Reserved